Physician profile
David Heydt
NPI 1194971622
$276.04
in general payments reported to CMS, 2019-2025
5 companies · $67.22 in 2025
The $67.22 reported for 2025 was less than what a typical Anatomic Pathology provider received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.65 · 2021: $47.49 · 2022: $23.65 · 2023: $57.55 · 2024: $62.48 · 2025: $67.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $199.83 | 2019-2025 | Iscan Coreo, Benchmark Ultra, Cintec Plus Cytology |
| Indivior INC. | $25.00 | 2025 | Sublocade |
| Meridian Bioscience INC. | $19.23 | 2023-2024 | |
| Leica Microsystems INC. | $18.00 | 2024 | Histocore Spectra St |
| Werfen USA LLC | $13.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heydt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.